What is the genetic inheritance pattern of Charcot-Marie-Tooth (CMT) disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Genetic Inheritance Pattern of Charcot-Marie-Tooth Disease

Charcot-Marie-Tooth disease is inherited primarily in an autosomal dominant pattern, which is the most common mode of transmission, though X-linked and autosomal recessive patterns also occur. 1, 2, 3

Primary Inheritance Patterns

Autosomal Dominant Inheritance (Most Common)

  • Autosomal dominant inheritance accounts for the majority of CMT cases, particularly CMT1 (demyelinating) and CMT2 (axonal) subtypes 1, 2, 4
  • CMT1A, caused by PMP22 gene duplication, represents approximately 70% of CMT1 cases and follows autosomal dominant inheritance 1, 2
  • Each affected individual has a 50% chance of transmitting the mutation to offspring 1
  • Approximately 22.7% to 30% of CMT cases result from de novo mutations, meaning affected individuals may have no family history 2, 5

X-Linked Inheritance

  • X-linked CMT (CMTX) is caused by mutations in the Cx32/GJB1 gene and accounts for approximately 12% of all CMT cases 1, 2, 3
  • Males are typically more severely affected than carrier females 1
  • CMTX can present with either demyelinating or axonal phenotypes on electrodiagnostic studies 1
  • The pedigree pattern shows no male-to-male transmission, which distinguishes it from autosomal dominant inheritance 1

Autosomal Recessive Inheritance (Less Common)

  • Autosomal recessive forms are less frequent but include severe early-onset variants 3, 4, 6
  • Both parents must be carriers, with a 25% recurrence risk for each pregnancy 6
  • These forms often present with more severe phenotypes, such as Déjérine-Sottas syndrome (HMSN-III) 6

Genotype-Specific Inheritance Patterns

CMT1 (Demyelinating Forms)

  • CMT1A (PMP22 duplication): Autosomal dominant - accounts for 70% of CMT1 cases and 76-90% of sporadic CMT1 cases 1, 2
  • MPZ mutations: Autosomal dominant - account for approximately 5% of CMT cases 1
  • PMP22 point mutations: Autosomal dominant - account for approximately 2.5% of CMT cases 1
  • EGR2 and LITAF mutations: Autosomal dominant - rare causes 1

CMT2 (Axonal Forms)

  • MFN2 mutations: Autosomal dominant - account for approximately 33% of CMT2 cases 1, 2
  • Other CMT2-associated genes (RAB7, GARS, NEFL, HSPB1): Predominantly autosomal dominant 1

CMTX (X-Linked Forms)

  • Cx32/GJB1 mutations: X-linked dominant - account for 12% of all CMT cases 1, 2, 3

Clinical Implications for Genetic Counseling

Family History Assessment

  • Obtain a three-generation pedigree focusing on symptoms of peripheral neuropathy, foot deformities, and gait abnormalities 2
  • Look for patterns suggesting autosomal dominant (affected individuals in multiple generations, male-to-male transmission possible) versus X-linked (no male-to-male transmission, affected males more severe than carrier females) 1

Sporadic Cases

  • Even without family history, genetic testing is warranted as 22.7-30% of mutations are de novo 2, 5
  • CMT1A duplication accounts for 76-90% of sporadic CMT1 cases 1

Recurrence Risk Counseling

  • For autosomal dominant forms: 50% risk to each offspring of an affected individual 1
  • For X-linked forms: 50% of male offspring of carrier females will be affected; 50% of female offspring will be carriers 1
  • For autosomal recessive forms: 25% recurrence risk if both parents are carriers 6

Common Pitfalls in Understanding Inheritance

  • Assuming no genetic cause when family history is negative - up to 30% of cases are de novo mutations 2, 5
  • Missing X-linked inheritance when pedigree is uninformative - lack of male-to-male transmission may not be apparent in small families 1
  • Overlooking variable expressivity in autosomal dominant forms - some carriers may have minimal symptoms, leading to apparent "skipped generations" 1
  • Failing to recognize that the same gene can cause different phenotypes - for example, MPZ mutations can cause severe early-onset disease or mild late-onset disease depending on the specific mutation 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Charcot-Marie-Tooth Disease Clinical Features and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Classification of Polyneuropathy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Charcot-Marie-tooth disease.

Foot & ankle specialist, 2008

Research

Genetic epidemiology of Charcot-Marie-Tooth disease.

Acta neurologica Scandinavica. Supplementum, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.